Disclosure statement
AP is consultant at Dedham Group and Oncology Reimbursement Management. MCH is consultant at Novartis, Molecular MD and holds equity interest in Molecular MD.
PDF download + Online access
Issue Purchase
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.
Register now or learn more